A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer.

Saved in:
Bibliographic Details
Title: A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer.
Authors: Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan. takuya.tsujino@ompu.ac.jp.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan. takuya.tsujino@ompu.ac.jp., Yamazaki S; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Sakamoto M; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan., Yoshikawa Y; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Maenosono R; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan., Nakajima Y; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Hirosuna K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan., Takai T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Nishimura K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan.; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ishida M; Department of Pathology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Nakamura K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Iwatsuki K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Tsuchida S; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Matsuda T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Higashio T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Fukushima T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Nishio K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Nakamori K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Tsutsumi T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Matsunaga T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Taniguchi K; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan., Shimbo T; Department of Radiation Oncology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Tanaka T; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan., Takahara K; Department of Urology, Fujita-Health University School of Medicine, Aichi, Japan., Inamoto T; Department of Urology, Hamamatsu University School of Medicine, Shizuoka, Japan., Hirose Y; Department of Pathology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Ono F; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan., Yamamoto K; Department of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Nihei K; Department of Radiation Oncology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Osuga K; Department of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Jia L; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kibel AS; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Komura K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan. k.komura@med.kawasaki-m.ac.jp.; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan. k.komura@med.kawasaki-m.ac.jp.; Department of Urology, Kawasaki Medical School, Okayama, Japan. k.komura@med.kawasaki-m.ac.jp., Yoshimi A; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan. ayoshimi@ncc.go.jp., Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 Jul 02; Vol. 11 (1). Date of Electronic Publication: 2026 Jul 02.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-3635
DOI:10.1038/s41392-026-02847-6